Skip to content

Minimally invasive versus convencional surgery for the treatment of displaced fractures of the clavicle shaft: a randomized multicentric pragmatic clinical trial

MIO vs ORIF in the treatment of displaced fractures of the clavicle shaft: a randomized multicentric pragmatic clinical trial - BRICS BRICS – Brazilian Multicentric Pragmatic Randomized Trial of Surgical Interventions for displaced Diaphyseal Clavicle Fracture Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-3czz68
Enrollment
Unknown
Registered
2020-11-03
Start date
2021-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clavicle fracture

Interventions

Experimental group: 95 patients will be submitted to minimally invasive osteosynthesis of displaced fracture of the diaphysis of the clavicle, using non locking reconstruction plate in a superior posi
Q65.070

Sponsors

Adriano Fernando Mendes Junior
Lead Sponsor
Adriano Fernando Mendes Junior
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: healthy volunteers; both genders; age over 18 years; with displaced fractures of the shaft of the clavicle type 2B according to Robinson's classification; evolution of up to 21 days.

Exclusion criteria

Exclusion criteria: patients with open fractures of the clavicle; with associated vascular or nerve injuries; with fractures of the shaft of the clavicle with joint extension; with concomitant fractures or dislocations in the shoulder girdle; with other fractures in the same upper limb; with a history of previous fractures in the clavicle; with a history of previous trauma to the shoulder girdle; with pathological fractures; patients with metabolic diseases; patients with congenital deformities on the same limb

Design outcomes

Primary

MeasureTime frame
Assess the number of complications of each technique. Complications will be considered cases of superficial or deep infection, hypertrophic scarring, pseudoarthrosis, refracture, implant failure, skin irritation and shoulder pain, except for hypoesthesia. The number of complications is a discrete numerical variable whose values will be accounted for in a twelve-month postoperative follow-up period.;Evaluate the number of re-operations for each technique. Re-operations will be considered for cases that require a new surgical intervention such as deep infection, pseudoarthrosis, refracture, implant failure and scheduled implant removal. The number of re-operations is a discrete numerical variable whose values will be accounted for in a twelve-month period of postoperative follow-up.

Secondary

MeasureTime frame
Pain assessment using the visual analogic scale (VAS). The questionnaire will be applied by an examiner blinded to the surgical procedure, with a patient wearing clothing (T-shirt), which will cover the incision and allow movements of the evaluation. The score is a continuous numeric variable that will be measured at 45, 180 and 360 days. The absolute difference and percentage of values between the periods for each participant and between experimental and control groups will be evaluated.;Quality od Life assessment using the SF-12 scale. The questionnaire will be applied by an examiner blinded to the surgical procedure, with a patient wearing clothing (T-shirt), which will cover the incision and allow movements of the evaluation. The score is a continuous numeric variable that will be measured at 45, 180 and 360 days. The absolute difference and percentage of values between the periods for each participant and between experimental and control groups will be evaluated.;Functional assessment using the DASH score. The questionnaire will be applied by an examiner blinded to the surgical procedure, with a patient wearing clothing (T-shirt), which will cover the incision and allow movements of the evaluation. The score is a continuous numeric variable that will be measured at 45, 180 and 360 days. The absolute difference and percentage of values between the periods for each participant and between experimental and control groups will be evaluated.;Functional assessment using the Constant score. The questionnaire will be applied by an examiner blinded to the surgical procedure, with a patient wearing clothing (T-shirt), which will cover the incision and allow movements of the evaluation. The score is a continuous numeric variable that will be measured at 45, 180 and 360 days. The absolute difference and percentage of values between the periods for each participant and between experimental and control groups will be evaluated.;Clinical evaluation with shoulder range of moti

Countries

Brazil

Contacts

Public ContactAdriano;Marcel Mendes Jr;Tamaoki

Hospital Universitário da Universidade Federal de Juiz de Fora;DOT - DEPARTAMENTO DE ORTOPEDIA UNIFESP

adrianofmjr@yahoo.com.br;marceltamaoki@gmail.com+5532985104433;+551155764848

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 14, 2026